| 500 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|
| 501 |
Excessive iron accumulation leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2149: Increased intracelluar Iron accumulation
|
2150: Neurological disorder
|
|
|
| 504 |
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Martina Panzarea |
BY-SA |
2155: Inhibition of Sulfotransferase E1 (SULT1E1)
|
1065: Activation, estrogen receptor alpha
|
|
|
| 519 |
Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality |
Young Jun Kim |
Open for adoption |
2282: Cardiac ion channels blockade
|
1929: Increased incidence of cardiovascular morbidity and mortality in the general population
|
|
|
| 520 |
Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
341: Impairment, Learning and memory
|
|
|
| 521 |
Essential element imbalance leads to reproductive failure via oxidative stress |
Travis Karschnik |
BY-SA |
2205: Increased, essential element imbalance
|
2147: Decreased, Viable Offspring
|
|
|
| 522 |
Estrogen antagonism leading to increased risk of autism-like behavior |
Kanglong Cui |
Open for adoption |
112: Antagonism, Estrogen receptor
|
2209: autism-like behavior
|
|
|
| 523 |
Retinoic acid receptor agonism during neurodevelopment leading to microcephaly |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
1978: Increase risk, microcephaly
|
|
|
| 525 |
Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory |
Ellen Fritsche |
Open for adoption |
4 MIEs
|
341: Impairment, Learning and memory
|
|
|
| 526 |
Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis |
John Frisch |
BY-SA |
None
|
1758: Impaired, Spermatogenesis
|
|
|
| 527 |
Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased |
John Frisch |
BY-SA |
None
|
2082: Hypospadias, increased
|
|
|
| 539 |
Decreased Sodium/Potassium ATPase activity leads to Heart failure |
John Frisch |
BY-SA |
1562: Decreased Na/K ATPase activity
|
1535: Heart failure
|
|
|
| 540 |
Oxidative Stress in the Fish Ovary Leads to Reproductive Impairment via Reduced Vitellogenin Production |
Kevin Brix |
BY-SA |
1115: Increase, Reactive oxygen species
|
360: Decrease, Population growth rate
|
|
|
| 541 |
Excessive ROS generation leading to increased incidence of vascular calcification by VSMC phenotype switching |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 543 |
Inhibition of neuropathy target esterase leading to delayed neuropathy via lysolecithin cell membrane integration |
Brooke Bowe |
BY-SA |
2262: Neuropathy target esterase, inhibited
|
2267: Delayed neuropathy, increased
|
|
|
| 544 |
Inhibition of neuropathy target esterase leading to delayed neuropathy via increased inflammation |
Brooke Bowe |
BY-SA |
2262: Neuropathy target esterase, inhibited
|
2267: Delayed neuropathy, increased
|
|
|
| 545 |
Activation, Pregnane-X receptor, NR1I2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis |
John Frisch |
BY-SA |
239: Activation, Pregnane-X receptor, NR1I2
|
2271: Increased, plasma low-density lipoprotein (LDL) cholesterol
|
|
|
| 546 |
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms |
Sylvie Bortoli |
BY-SA |
2118: Succinate dehydrogenase, inhibited
|
885: Increase, Cancer
|
|
|
| 484 |
Bisphenol A analogs induce cellular dysfunction in human trophoblast cells in a thyroid hormone receptor-dependent manner: in silico and in vitro analyses |
Xiaoyun Wu |
BY-SA |
None
|
None
|
|
|
| 485 |
Thyroid hormone antagonism leading to impaired oligodendrocyte maturation during development and subsequent decreased cognition |
Eliska Kuchovska |
BY-SA |
1656: Antagonism, Thyroid Receptor
|
402: Cognitive function, decreased
|
|
|
| 486 |
Binding to the extracellular protein laminin leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
2109: Binding, extracellular matrix protein laminin
|
402: Cognitive function, decreased
|
|
|
| 487 |
Unknown MIE altering cholesterol metabolism leading to decreased cognition |
Eliska Kuchovska |
BY-SA |
1114: Unknown, MIE
|
402: Cognitive function, decreased
|
|
|
| 488 |
Increased reactive oxygen species production leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
1115: Increase, Reactive oxygen species
|
402: Cognitive function, decreased
|
|
|
| 489 |
Inhibition of voltage-gated sodium channels leading to decreased cognition |
Lidwina Gerner |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
|
|
| 490 |
Co-activation of IP3R and RyR leads to reduced IQ and increased socio-economic burden through non-cholinergic mechanisms |
Karine Audouze |
BY-SA |
2 MIEs
|
3 AOs
|
|
|